Abstract
Diffuse large B-cell lymphoma (DLBCL) is one of the most common progressive B-cell non-Hodgkin lymphoma affected by varieties of factors, which is featured by strong heterogeneity in clinic and prognosis. This review discusses the prognostic factors affecting DLBCL patients in both clinical and molecular biology characteristics according to domestic and abroad research progress. Key words: Lymphoma, large B-cell, diffuse; Prognosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
